Teladoc Health Inc
NYSE:TDOC
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
US |
Teladoc Health Inc
NYSE:TDOC
|
2.2B USD | 0.8 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 13.7 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | ||
JP |
M3 Inc
TSE:2413
|
1.3T JPY | 5.4 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 78.1 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 11.2 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.5 | ||
SE |
Sectra AB
STO:SECT B
|
42.7B SEK | 26.1 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.8 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.